HIGHLIGHTS
- who: Camilla Huse from the Research Institute Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo have published the research work: Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial, in the Journal: (JOURNAL)
- what: The authors analysed a wide range of lymphocyte subpopulations in the ASSAIL-MI study.
- how: In this predefined exploratory sub-study of the ASSAIL-MI trial the authors examined the effect of tocilizumab on a broad spectrum of leukocyte subpopulations. criteria as well as the study design have been published elsewhere .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.